Early surrogates of outcome after thrombectomy in posterior circulation stroke.

early neurological improvement outcome posterior circulation stroke prediction thrombectomy

Journal

European journal of neurology
ISSN: 1468-1331
Titre abrégé: Eur J Neurol
Pays: England
ID NLM: 9506311

Informations de publication

Date de publication:
11 2022
Historique:
revised: 30 07 2022
received: 30 06 2022
accepted: 01 08 2022
pubmed: 8 8 2022
medline: 12 10 2022
entrez: 7 8 2022
Statut: ppublish

Résumé

Early surrogates for functional outcome in anterior circulation stroke have been described with the National Institute of Health Stroke Scale (NIHSS) at 24 h being reported as the most accurate metric. We compare discriminatory power of established definitions of early neurological improvement (ENI) and NIHSS scores at admission and 24 h to predict functional outcome at 90 days after thrombectomy in posterior circulation stroke (PCS). All patients enrolled in the German Stroke Registry (June 2015-December 2019) with PCS and at least vertebral or basilar artery occlusions were included. NIHSS admission, 24 h and ENI definitions (improvement of 8/10 NIHSS points or 0/1 NIHSS points at 24 h) were compared for predicting functional outcome at 90 days. Favourable and good outcome were defined as modified Rankin Scale (mRS) 0-2 and 0-3. Multivariable logistic regression analysis was conducted to identify factors impairing predictive power. Three hundred and eighty-seven patients were included. NIHSS 24 h had the highest discriminative power with receiver operator characteristics area under the curve of 0.87 (95% confidence interval: 0.83; 0.90) for good and 0.89 (0.85; 0.92) for favourable outcome; optimal cut-off values were ≤9 and ≤5. Higher age (odds ratio = 1.10 [1.05; 1.16]), adverse events during treatment (9.46 [1.52; 72.5]) and until discharge (18.34 [2.33; 172]) and high NIHSS scores at 24 h (1.29 [1.10; 1.53]) were independent predictors for turning the outcome prognosis from good (mRS ≤3) to poor (mRS ≥4). NIHSS 24 h ≤9 points serves best as surrogate for good functional outcome after thrombectomy in PCS. Advanced age, severe neurological symptoms at admission and adverse events decrease its predictive value.

Sections du résumé

BACKGROUND
Early surrogates for functional outcome in anterior circulation stroke have been described with the National Institute of Health Stroke Scale (NIHSS) at 24 h being reported as the most accurate metric. We compare discriminatory power of established definitions of early neurological improvement (ENI) and NIHSS scores at admission and 24 h to predict functional outcome at 90 days after thrombectomy in posterior circulation stroke (PCS).
METHODS
All patients enrolled in the German Stroke Registry (June 2015-December 2019) with PCS and at least vertebral or basilar artery occlusions were included. NIHSS admission, 24 h and ENI definitions (improvement of 8/10 NIHSS points or 0/1 NIHSS points at 24 h) were compared for predicting functional outcome at 90 days. Favourable and good outcome were defined as modified Rankin Scale (mRS) 0-2 and 0-3. Multivariable logistic regression analysis was conducted to identify factors impairing predictive power.
RESULTS
Three hundred and eighty-seven patients were included. NIHSS 24 h had the highest discriminative power with receiver operator characteristics area under the curve of 0.87 (95% confidence interval: 0.83; 0.90) for good and 0.89 (0.85; 0.92) for favourable outcome; optimal cut-off values were ≤9 and ≤5. Higher age (odds ratio = 1.10 [1.05; 1.16]), adverse events during treatment (9.46 [1.52; 72.5]) and until discharge (18.34 [2.33; 172]) and high NIHSS scores at 24 h (1.29 [1.10; 1.53]) were independent predictors for turning the outcome prognosis from good (mRS ≤3) to poor (mRS ≥4).
CONCLUSIONS
NIHSS 24 h ≤9 points serves best as surrogate for good functional outcome after thrombectomy in PCS. Advanced age, severe neurological symptoms at admission and adverse events decrease its predictive value.

Identifiants

pubmed: 35933692
doi: 10.1111/ene.15519
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3296-3306

Informations de copyright

© 2022 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.

Références

Meyer L, Broocks G, Bechstein M, et al. Early clinical surrogates for outcome prediction after stroke thrombectomy in daily clinical practice. J Neurol Neurosurg Psychiatry. 2020;91(10):1055-1059.
Rangaraju S, Frankel M, Jovin TG. Prognostic value of the 24-hour neurological examination in anterior circulation ischemic stroke: a post hoc analysis of two randomized controlled stroke trials. Interv Neurol. 2015;4(3-4):120-129.
Hendrix P, Melamed I, Collins M, et al. NIHSS 24h after mechanical thrombectomy predicts 90-day functional outcome. Clin Neuroradiol. 2021;32(2):401-406.
Sato S, Toyoda K, Uehara T, et al. Baseline NIH Stroke Scale Score predicting outcome in anterior and posterior circulation strokes. Neurology. 2008;70(24 Pt 2):2371-2377.
Lyden P. Using the National Institutes of Health Stroke Scale: A Cautionary Tale. Stroke. 2017;48(2):513-519.
World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191-2194.
Alegiani AC, Dorn F, Herzberg M, et al. Systematic evaluation of stroke thrombectomy in clinical practice: the German Stroke Registry Endovascular Treatment. Int J Stroke. 2019;14(4):372-380.
Wollenweber FA, Tiedt S, Alegiani A, et al. Functional outcome following stroke thrombectomy in clinical practice. Stroke. 2019;50(9):2500-2506.
Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). 1998;352(9136):1245-1251.
Langezaal LCM, van der Hoeven E, Mont'Alverne FJA, et al. Endovascular therapy for stroke due to basilar-artery occlusion. N Engl J Med. 2021;384(20):1910-1920.
Broderick JP, Lu M, Kothari R, et al. Finding the most powerful measures of the effectiveness of tissue plasminogen activator in the NINDS tPA stroke trial. Stroke. 2000;31(10):2335-2341.
Brown DL, Johnston KC, Wagner DP, Haley EC Jr. Predicting major neurological improvement with intravenous recombinant tissue plasminogen activator treatment of stroke. Stroke. 2004;35(1):147-150.
Haley EC Jr, Lewandowski C, Tilley BC. Myths regarding the NINDS rt-PA stroke trial: setting the record straight. Ann Emerg Med. 1997;30(5):676-682.
Alexandrov AV, Demchuk AM, Felberg RA, et al. High rate of complete recanalization and dramatic clinical recovery during tPA infusion when continuously monitored with 2-MHz transcranial doppler monitoring. Stroke. 2000;31(3):610-614.
Mistry EA, Yeatts S, Havenon A, et al. Predicting 90-day outcome after thrombectomy: baseline-adjusted 24-hour NIHSS is more powerful than NIHSS score change. Stroke. 2021;52(8):2547-2553.
Heit JJ, Mlynash M, Kemp SM, et al. Rapid neurologic improvement predicts favorable outcome 90 days after thrombectomy in the DEFUSE 3 study. Stroke. 2019;50(5):1172-1177.
Turc G, Bhogal P, Fischer U, et al. European Stroke Organisation (ESO) - European Society for Minimally Invasive Neurological Therapy (ESMINT) guidelines on mechanical thrombectomy in acute ischemic stroke. J Neurointerv Surg. 2019;11:535-538.
Sarraj A, Hassan A, Savitz SI, et al. Endovascular thrombectomy for mild strokes: how low should we go? Stroke. 2018;49(10):2398-2405.
Guenego A, Bourcier R, Guillen M, et al. Neurological improvement predicts clinical outcome after acute basilar artery stroke thrombectomy. Eur J Neurol. 2021;28(1):117-123.
Meyer L, Alexandrou M, Flottmann F, et al. Endovascular treatment of very elderly patients aged ≥90 with acute ischemic stroke. J Am Heart Assoc. 2020;9(5):e014447.
Meyer L, Alexandrou M, Leischner H, et al. Mechanical thrombectomy in nonagenarians with acute ischemic stroke. J Neurointerv Surg. 2019;11(11):1091-1094.
Meyer L, Schönfeld M, Bechstein M, et al. Ischemic lesion water homeostasis after thrombectomy for large vessel occlusion stroke within the anterior circulation: the impact of age. J Cereb Blood Flow Metab 2021;41(1):45-52.
Cai H, Han Y, Sun W, et al. Delayed neurological improvement is predictive to long-term clinical outcome on endovascular thrombectomy patients. Interv Neuroradiol. 2022;28(4):404-410.
Weyland CS, Neuberger U, Potreck A, et al. Reasons for failed mechanical thrombectomy in posterior circulation ischemic stroke patients. Clin Neuroradiol. 2021;31(3):745-752.
Talavera B, Gómez-Vicente B, Martínez-Galdámez M, et al. Delayed neurological improvement after full endovascular reperfusion in acute anterior circulation ischemic stroke. Stroke. 2021;52(7):2210-2217.
Meurer WJ. Delayed neurological improvement. Stroke. 2021;52(7):2218-2219.
Alexandrov AV, Hall CE, Labiche LA, Wojner AW, Grotta JC. Ischemic stunning of the brain. Stroke. 2004;35(2):449-452.
Suda S, Aoki J, Shimoyama T, et al. Stroke-associated infection independently predicts 3-month poor functional outcome and mortality. J Neurol. 2018;265(2):370-375.
Bucker A, Boers AM, Bot JCJ, et al. Associations of ischemic lesion volume with functional outcome in patients with acute ischemic stroke. Stroke. 2017;48(5):1233-1240.

Auteurs

Helge Kniep (H)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Matthias Bechstein (M)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Gabriel Broocks (G)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Caspar Brekenfeld (C)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Fabian Flottmann (F)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Noel van Horn (N)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Vincent Geest (V)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Tobias D Faizy (TD)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Milani Deb-Chatterji (M)

Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Anna Alegiani (A)

Department of Neurology, Asklepios Klinik Altona, Hamburg, Germany.

Götz Thomalla (G)

Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Susanne Gellißen (S)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Jens Fiehler (J)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Uta Hanning (U)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Lukas Meyer (L)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH